Angiotensin-(1–7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism
Open accessThe DOI matches its Crossref record; 66 of the 69 references it cites were found in a registry or an index.
Abstract
Skeletal muscle atrophy is a pathological condition characterized by the loss of strength and muscle mass, an increase in myosin heavy chain (MHC) degradation and increase in the expression of two muscle-specific ubiquitin ligases: atrogin-1 and MuRF-1. Angiotensin II (AngII) induces muscle atrophy. Angiotensin-(1–7) [Ang-(1–7)], through its receptor Mas, produces the opposite effects than AngII. We assessed the effects of Ang-(1–7) on the skeletal muscle atrophy induced by AngII. Our results show that Ang-(1–7), through Mas, prevents the effects induced by AngII in muscle gastrocnemius: the decrease in the fibre diameter, muscle strength and MHC levels and the increase in atrogin-1 and MuRF-1. Ang-(1–7) also induces AKT phosphorylation. In addition, our analysis in vitro using C2C12 myotubes shows that Ang-(1–7), through a mechanism dependent on Mas, prevents the decrease in the levels of MHC and the increase in the expression of the atrogin-1 and MuRF-1, both induced by AngII. Ang-(1–7) induces AKT phosphorylation in myotubes; additionally, we demonstrated that the inhibition of AKT with MK-2206 decreases the anti-atrophic effects of Ang-(1–7). Thus, we demonstrate for the first time that Ang-(1–7) counteracts the skeletal muscle atrophy induced by AngII through a mechanism dependent on the Mas receptor, which involves AKT activity. Our study indicates that Ang-(1–7) is novel molecule with a potential therapeutical use to improve muscle wasting associated, at least, with pathologies that present high levels of AngII.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding skeletal muscle, there is broad evidence about the antiatrophic and antisarcopenic role of Ang-(1-7) [141–144].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [141]
Citations
Cites
1 retracted
Lokireddy, S., McFarlane, C., Ge, X., Zhang, H., Sze, S. K., Sharma, M., & Kambadur, R. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1124 · Cited by 117
RetractedIdentification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal Muscle
Clarke, B. A., Drujan, D., Willis, M. S., Murphy, L. O., Corpina, R. A., Burova, E., Rakhilin, S. V., Stitt, T. N., Patterson, C., Latres, E., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.009 · Cited by 683
Cohen, S., Brault, J. J., Gygi, S. P., Glass, D. J., Valenzuela, D. M., Gartner, C., Latres, E., & Goldberg, A. L. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200901052 · Cited by 584
Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000251865.35728.2f · Cited by 562
Molecular mechanisms modulating muscle mass
Glass, D. J. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00138-2 · Cited by 440
Intracellular signaling during skeletal muscle atrophy
Kandarian, S. C., & Jackman, R. W. (2006) · Muscle & Nerve · doi:10.1002/mus.20442 · Cited by 393
Ferrario, C. M., Trask, A. J., & Jessup, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2005 · Cited by 385
Atrogin-1, MuRF-1, and sarcopenia
Gumucio, J. P., & Mendias, C. L. (2013) · Endocrine · doi:10.1007/s12020-012-9751-7 · Cited by 370
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
Foletta, V. C., White, L. J., Larsen, A. E., Léger, B., & Russell, A. P. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0919-9 · Cited by 357
Lagirand‐Cantaloube, J., Offner, N., Csibi, A., Leibovitch, M. P., Batonnet‐Pichon, S., Tintignac, L. A., Segura, C. T., & Leibovitch, S. A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.52 · Cited by 328
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Measuring the Strength of Mice
Deacon, R. M. J. (2013) · Journal of Visualized Experiments · doi:10.3791/2610 · Cited by 281
Brink, M., Wellen, J., & Delafontaine, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118698 · Cited by 262
Iwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X.-J., & Greenberg, B. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00317.2005 · Cited by 231
Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
Benter, I. F., Ferrario, C. M., Morris, M., & Diz, D. I. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.1.h313 · Cited by 225
Brink, M., Price, S. R., Chrast, J., Bailey, J. L., Anwar, A., Mitch, W. E., & Delafontaine, P. (2001) · Endocrinology · doi:10.1210/en.142.4.1489 · Cited by 212
Satellite Cell Dysfunction and Impaired IGF-1 Signaling Cause CKD-Induced Muscle Atrophy
Zhang, L., Wang, X. H., Wang, H., Du, J., & Mitch, W. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060571 · Cited by 206
Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo
Lagirand-Cantaloube, J., Cornille, K., Csibi, A., Batonnet-Pichon, S., Leibovitch, M. P., & Leibovitch, S. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004973 · Cited by 202
Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
Dias-Peixoto, M. F., Santos, R. A. S., Gomes, E. R. M., Alves, M. N. M., Almeida, P. W. M., Greco, L., Rosa, M., Fauler, B., Bader, M., Alenina, N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114280 · Cited by 163
Acuña, M. J., Pessina, P., Olguin, H., Cabrera, D., Vio, C. P., Bader, M., Muñoz-Canoves, P., Santos, R. A., Cabello-Verrugio, C., & Brandan, E. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt514 · Cited by 158
Self-citationReducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
Morales, M. G., Gutierrez, J., Cabello-Verrugio, C., Cabrera, D., Lipson, K. E., Goldschmeding, R., & Brandan, E. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt352 · Cited by 145
Self-citationSanders, P. M., Russell, S. T., & Tisdale, M. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602725 · Cited by 142
Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting
Lokireddy, S., Wijesoma, I. W., Sze, S. K., McFarlane, C., Kambadur, R., & Sharma, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2011 · Cited by 125
Agarwal, R., & Chase), (. T. T. A. O. S. D. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00385.2002 · Cited by 124
Lokireddy, S., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M., Kambadur, R., & McFarlane, C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00114.2011 · Cited by 121
Yoshida, T., Semprun-Prieto, L., Sukhanov, S., & Delafontaine, P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00146.2010 · Cited by 120
Cozzone, D., Fröjdö, S., Disse, E., Debard, C., Laville, M., Pirola, L., & Vidal, H. (2008) · Diabetologia · doi:10.1007/s00125-007-0913-8 · Cited by 111
CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy
Morales, M. G., Cabello‐Verrugio, C., Santander, C., Cabrera, D., Goldschmeding, R., & Brandan, E. (2011) · The Journal of Pathology · doi:10.1002/path.2952 · Cited by 107
Self-citationThe role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle
Henriksen, E. J., & Prasannarong, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.011 · Cited by 96
Russell, S. T., Eley, H. L., & Tisdale, M. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.003 · Cited by 92
Agarwal, R., Campbell, R. C., & Warnock, D. G. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2003.11.008 · Cited by 89
Cabello‐Verrugio, C., Morales, M. G., Cabrera, D., Vio, C. P., & Brandan, E. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01354.x · Cited by 84
Self-citationAngiotensin II induced catabolic effect and muscle atrophy are redox dependent
Semprun-Prieto, L. C., Sukhanov, S., Yoshida, T., Rezk, B. M., Gonzalez-Villalobos, R. A., Vaughn, C., Michael Tabony, A., & Delafontaine, P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.122 · Cited by 83
Angiotensin II Inhibits Satellite Cell Proliferation and Prevents Skeletal Muscle Regeneration
Yoshida, T., Galvez, S., Tiwari, S., Rezk, B. M., Semprun-Prieto, L., Higashi, Y., Sukhanov, S., Yablonka-Reuveni, Z., & Delafontaine, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.449074 · Cited by 83
Morales, M. G., Vázquez, Y., Acuña, M. J., Rivera, J. C. A., Simón, F., Salas, J. D., Álvarez‐Ruf, J., Brandan, E., & Cabello‐Verrugio, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.028 · Cited by 83
Self-citationOhshima, K., Mogi, M., Nakaoka, H., Iwanami, J., Min, L.-J., Kanno, H., Tsukuda, K., Chisaka, T., Bai, H.-Y., Wang, X.-L., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02426 · Cited by 82
Morales, M. G., Cabrera, D., Céspedes, C., Vio, C. P., Vázquez, Y., Brandan, E., & Cabello‐Verrugio, C. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1642-6 · Cited by 80
Self-citationMechanism of induction of muscle protein degradation by angiotensin II
Russell, S. T., Wyke, S. M., & Tisdale, M. J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.09.009 · Cited by 79
Muñoz, M. C., Giani, J. F., & Dominici, F. P. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.02.001 · Cited by 69
Cabello‐Verrugio, C., Acuña, M. J., Morales, M. G., Becerra, Á., Simón, F., & Brandan, E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.051 · Cited by 69
Self-citationAngiotensin 1–7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo
Echeverría‐Rodríguez, O., del Valle‐Mondragón, L., & Hong, E. (2013) · Peptides · doi:10.1016/j.peptides.2013.10.022 · Cited by 68
The Mas receptor mediates modulation of insulin signaling by angiotensin-(1–7)
Muñoz, M. C., Giani, J. F., Burghi, V., Mayer, M. A., Carranza, A., Taira, C. A., & Dominici, F. P. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.04.001 · Cited by 67
Lopez Verrilli, M. A., Pirola, C. J., Pascual, M. M., Dominici, F. P., Turyn, D., & Gironacci, M. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05912.x · Cited by 65
Prasannarong, M., Santos, F. R., & Henriksen, E. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.093 · Cited by 59
Angiotensin II Infusion Induces Marked Diaphragmatic Skeletal Muscle Atrophy
Rezk, B. M., Yoshida, T., Semprun-Prieto, L., Higashi, Y., Sukhanov, S., & Delafontaine, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030276 · Cited by 59
ACE2 Is Augmented in Dystrophic Skeletal Muscle and Plays a Role in Decreasing Associated Fibrosis
Riquelme, C., Acuña, M. J., Torrejón, J., Rebolledo, D., Cabrera, D., Santos, R. A., & Brandan, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093449 · Cited by 59
Self-citationMorales, M. G., Ábrigo, J., Meneses, C., Simon, F., Cisternas, F., Rivera, J. C., Vazquez, Y., & Cabello-Verrugio, C. (2014) · Clinical Science · doi:10.1042/cs20130585 · Cited by 51
Self-citationSabharwal, R., Cicha, M. Z., Sinisterra, R. D. M., De Sousa, F. B., Santos, R. A., & Chapleau, M. W. (2014) · Clinical Science · doi:10.1042/cs20130602 · Cited by 38
Painemal, P., Acuña, M. J., Riquelme, C., Brandan, E., & Cabello‐Verrugio, C. (2013) · BioFactors · doi:10.1002/biof.1087 · Cited by 37
Self-citationKackstein, K., Teren, A., Matsumoto, Y., Mangner, N., Möbius‐Winkler, S., Linke, A., Schuler, G. C., Punkt, K., & Adams, V. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.09.009 · Cited by 34
Meinen, S., Lin, S., Rüegg, M. A., & Punga, A. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044148 · Cited by 34
Angiotensin II and Cardiac Fibrosis
Brecher, P. I. (1996) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(96)00072-2 · Cited by 33
Angiotensin II type 1 receptor blocker inhibits pulmonary injury.
Mancini, G. B. J., & Khalil, N. (2005) · PubMed · Cited by 32
Marangoni, R. A., Carmona, A. K., Tostes, R. C., Nigro, D., Fortes, Z. B., & de Carvalho, M. H. C. (2006) · Peptides · doi:10.1016/j.peptides.2006.02.002 · Cited by 21
Sabharwal, R., & Chapleau, M. W. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.074336 · Cited by 19
Angiotensin‐(1‐7)/Angiotensin‐Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
Ferreira, A. J., Santos, R. A. S., & Raizada, M. K. (2012) · International Journal of Hypertension · doi:10.1155/2012/690785 · Cited by 15
Targeting the angiotensin pathway in idiopathic pulmonary fibrosis
Antoniu, S. A. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802515459 · Cited by 12
Cited by
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle
Cabello‐Verrugio, C., Morales, M. G., Rivera, J. C., Cabrera, D., & Simon, F. (2015) · Medicinal Research Reviews · doi:10.1002/med.21343 · Cited by 165
Self-citationAbrigo, J., Rivera, J. C., Aravena, J., Cabrera, D., Simon, F., Ezquer, F., Ezquer, M., & Cabello-Verrugio, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9047821 · Cited by 109
“Fibers were handled manually, and the minimal Feret diameter of each fiber was computed by the software [28, 29].”
Self-citationKarnik, S. S., Singh, K. D., Tirupula, K., & Unal, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13742 · Cited by 105
“…production of TGF-β1 and collagen in cardiac fibroblasts (Meng et al., 2014; Tao et al., 2014; Zheng et al., 2015a), muscle atrophy of gastrocnemius (Cisternas et al., 2014), pancreatic cell damage (Wang et al., 2014), ICAM-1, VCAM-1, and MCP-1 expression in HUVECs (Liang et al., 2015a,b) is…”
BackgroundAngiotensins as therapeutic targets beyond heart disease
Passos-Silva, D. G., Brandan, E., & Santos, R. A. S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.001 · Cited by 99
Self-citation
Metadata
- Authors
- Cisternas, F., Morales, M. G., Meneses, C., Simon, F., Brandan, E., Abrigo, J., Vazquez, Y., & Cabello-Verrugio, C.
- Affiliations
- Universidad Andrés Bello (CL)
- Laboratorio de Fisiopatología Integrativa, Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas & Facultad de Medicina, Universidad Andres Bello, Santiago, Chile
- Pontificia Universidad Católica de Chile (CL)
- Laboratorio de Biología y Fisiopatología Molecular, Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas & Facultad de Medicina, Universidad Andres Bello, Santiago, Chile
- Corresponding author
- Cisternas, Franco
- Meneses, Carla
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2014-11-05
- Volume
- 128
- Issue
- 5
- Pages
- 307-319
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1974759520
- Cited by
- 83
- References
- 69
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 14 · 2020: 11 · 2019: 11 · 2018: 8 · 2017: 6 · 2016: 7 · 2015: 8
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- other-oa
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- angiotensin-(1-7), angiotensin II, skeletal muscle atrophy, Mas receptor, Akt phosphorylation, atrogin-1, MuRF1, myosin heavy chain degradation, ubiquitin ligase, muscle atrophy, gastrocnemius, MK-2206, C2C12 myotubes
- MeSH terms
- Tripartite Motif Proteins, Proto-Oncogene Mas, Angiotensin I, Angiotensin II, Animals, Cell Line, Gene Expression Regulation, Male, Mice, Inbred C57BL, Muscle Proteins, Muscular Atrophy, Peptide Fragments, Phosphorylation, Proto-Oncogene Proteins, Signal Transduction, Muscle, Skeletal, Muscle Fibers, Skeletal, Myosin Heavy Chains, Receptors, G-Protein-Coupled, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.